Page last updated: 2024-11-06

mitomycin and Conjunctival Neoplasms

mitomycin has been researched along with Conjunctival Neoplasms in 137 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Conjunctival Neoplasms: Tumors or cancer of the CONJUNCTIVA.

Research Excerpts

ExcerptRelevanceReference
"Local chemotherapy with mitomycin C is a useful option in the treatment of malignant melanomas of the conjunctiva associated with PAM if the tumor stage is pT3 or less."9.10[Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. ( Conway, RM; Groh, MJ; Holbach, LM; Kühnel, B; Naumann, GO, 2003)
"Topical mitomycin chemotherapy was found to induce regression of conjunctival melanoma and primary acquired melanosis with atypia."9.09Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. ( Demirci, H; Finger, PT; McCormick, SA, 2000)
"To evaluate topical mitomycin C (MMC) chemotherapy in the treatment of conjunctival melanoma and primary acquired melanosis with atypia."9.08Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. ( Czechonska, G; Finger, PT; Liarikos, S, 1998)
"To report a case of a large conjunctival melanoma (CM) successfully treated with surgical resection and pre- and postoperative topical mitomycin C (MMC)."8.02Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C. ( Giansanti, F; Mazzini, C; Nicolosi, C; Pieretti, G; Vicini, G; Virgili, G, 2021)
"To describe the clinical and histological resolution of a case of an inexcisable conjunctival melanoma using topical interferon alpha 2b (INFα2b) in a patient with mitomycin C (MMC) intolerance."7.88Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance. ( Chaparro Tapias, TA; Coy Villamil, H; Díaz Díaz, AL; Sánchez España, JC; Secondi, R, 2018)
"To report the long-term complications and rate of local recurrence in a cohort of patients with histopathologically confirmed conjunctival melanoma (CM) treated with adjuvant topical mitomycin C (MMC)."7.77Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. ( Ditta, LC; Shildkrot, Y; Wilson, MW, 2011)
"Sodium butyrate and trichostatin induced cell death in melanoma cells, comparable with mitomycin C, with minimal effect on Tenon capsule fibroblasts."7.75In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. ( Conway, RM; Cunneen, TS; Madigan, MC, 2009)
"To describe a case of recurrent, advanced conjunctival papillomatosis, treated by oral cimetidine (CIM) combined with secondary surgical intervention and an application of intraoperative mitomycin C."7.73Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. ( Chang, SW; Huang, ZL, 2006)
"Conjunctival melanoma and PAM responded to mitomycin 0."7.73Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. ( Finger, PT; Kurli, M, 2005)
"To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia."7.72Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003)
"To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma."7.71The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. ( Chan, NR; Chi, SC; Lam, DS; Yeung, EF; Yuen, HK, 2002)
" In this study we aimed to evaluate the effectivity of postsurgical chemotherapy of conjunctival squamous cell carcinoma in situ (CIN) with mitomycin C eyedrops."7.71[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. ( Böcking, A; Cartsburg, O; Kersten, A; Nadjari, B; Pomjanski, N; Sundmacher, R, 2001)
"Excision with application of mitomycin C was successful in managing a case of squamous papillomatosis that was resistant to traditional therapy."7.70Treatment of recurrent conjunctival papillomatosis with mitomycin C. ( Hamming, NA; Hawkins, AS; Rubenstein, JB; Yu, J, 1999)
"Since 1995 we have used Mitomycin C additionally in the treatment of conjunctival melanoma and primary acquired melanosis."7.70[Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]. ( Lommatzsch, PK; Werschnik, C, 1998)
"The lesion was diagnosed as invasive squamous cell carcinoma on histopathology and topical 0."5.37Periocular allergic contact dermatitis following topical Mitomycin C eye drop application. ( Cavdar, M; Cumurcu, T; Sener, S, 2011)
"We observed euploid DNA-polyploidy and cytomorphological changes in all patients (19/19)."5.31Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. ( Böcking, A; Cartsburg, O; Hillenkamp, J; Kallen, C; Pomjanski, N; Sundmacher, R, 2001)
" If Mitomycin is used in that low dosage and in that special application as shown, it could be a very efficient therapy with less complications."5.31[The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years]. ( Klaehsen, D; Maier, M; Merté, RL; Schmidt, M; Schmidt, T, 2001)
"Local chemotherapy with mitomycin C is a useful option in the treatment of malignant melanomas of the conjunctiva associated with PAM if the tumor stage is pT3 or less."5.10[Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. ( Conway, RM; Groh, MJ; Holbach, LM; Kühnel, B; Naumann, GO, 2003)
"Topical mitomycin chemotherapy was found to induce regression of conjunctival melanoma and primary acquired melanosis with atypia."5.09Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. ( Demirci, H; Finger, PT; McCormick, SA, 2000)
"To evaluate topical mitomycin C (MMC) chemotherapy in the treatment of conjunctival melanoma and primary acquired melanosis with atypia."5.08Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. ( Czechonska, G; Finger, PT; Liarikos, S, 1998)
"We herein compare topical interferon alpha 2b (IFN-α2b) to topical mitomycin C (MMC) in the adjuvant management after excision of primary acquired melanosis with atypia (PAM) and melanoma of the conjunctiva/cornea (CM)."4.31Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions. ( Auw-Haedrich, C; Boehringer, D; Jiang, J; Nuessle, S; Reinhard, T, 2023)
"To report a case of a large conjunctival melanoma (CM) successfully treated with surgical resection and pre- and postoperative topical mitomycin C (MMC)."4.02Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C. ( Giansanti, F; Mazzini, C; Nicolosi, C; Pieretti, G; Vicini, G; Virgili, G, 2021)
"To describe the clinical and histological resolution of a case of an inexcisable conjunctival melanoma using topical interferon alpha 2b (INFα2b) in a patient with mitomycin C (MMC) intolerance."3.88Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance. ( Chaparro Tapias, TA; Coy Villamil, H; Díaz Díaz, AL; Sánchez España, JC; Secondi, R, 2018)
"The recommended treatment for conjunctival melanoma is surgical removal with adjunctive therapies such as cryotherapy or topical mitomycin-C."3.80[Treatment of conjunctival melanoma]. ( Baamonde Arbaiza, B; de la Roz Martín, P; Parra Rodríguez, T; Salazar Méndez, R, 2014)
"To report the long-term complications and rate of local recurrence in a cohort of patients with histopathologically confirmed conjunctival melanoma (CM) treated with adjuvant topical mitomycin C (MMC)."3.77Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. ( Ditta, LC; Shildkrot, Y; Wilson, MW, 2011)
"Persistent epitheliopathy, presumably resulting from limbal stem cell deficiency, is an uncommon complication of treatment of conjunctival malignant melanoma with surgical excision, cryotherapy, and mitomycin C."3.76Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma. ( Colby, KA; Grover, S; Jacobs, DS, 2010)
"Sodium butyrate and trichostatin induced cell death in melanoma cells, comparable with mitomycin C, with minimal effect on Tenon capsule fibroblasts."3.75In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. ( Conway, RM; Cunneen, TS; Madigan, MC, 2009)
"Conjunctival melanoma and PAM responded to mitomycin 0."3.73Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. ( Finger, PT; Kurli, M, 2005)
"To describe a case of recurrent, advanced conjunctival papillomatosis, treated by oral cimetidine (CIM) combined with secondary surgical intervention and an application of intraoperative mitomycin C."3.73Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. ( Chang, SW; Huang, ZL, 2006)
"To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia."3.72Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003)
"To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma."3.71The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. ( Chan, NR; Chi, SC; Lam, DS; Yeung, EF; Yuen, HK, 2002)
" In this study we aimed to evaluate the effectivity of postsurgical chemotherapy of conjunctival squamous cell carcinoma in situ (CIN) with mitomycin C eyedrops."3.71[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. ( Böcking, A; Cartsburg, O; Kersten, A; Nadjari, B; Pomjanski, N; Sundmacher, R, 2001)
"Since 1995 we have used Mitomycin C additionally in the treatment of conjunctival melanoma and primary acquired melanosis."3.70[Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]. ( Lommatzsch, PK; Werschnik, C, 1998)
"To describe the epithelial changes observed in the conjunctiva secondary to the use of topical mitomycin C (MMC) for treatment of primary acquired melanosis with atypia."3.70Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. ( Cuevas, K; Folberg, R; Mathers, WD; Salomão, DR; Sutphin, JE, 1999)
"Excision with application of mitomycin C was successful in managing a case of squamous papillomatosis that was resistant to traditional therapy."3.70Treatment of recurrent conjunctival papillomatosis with mitomycin C. ( Hamming, NA; Hawkins, AS; Rubenstein, JB; Yu, J, 1999)
" Regarding adverse effects, one or more mild adverse reaction occurred in 77% of patients managed with MMC and in 50% of patients managed with IFNα2b (p > 0."3.30Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy. ( Alvarado-Castillo, B; Garcia-Benavides, L; Gonzalez-Castillo, C; Navarro-Partida, J; Rosales-Gradilla, ME; Santa Cruz-Pavlovich, FJ; Vidal-Paredes, IA, 2023)
"Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable."2.49Topical chemotherapy for ocular surface squamous neoplasia. ( Karp, CL; Nanji, AA; Sayyad, FE, 2013)
"Conjunctival melanoma is an exceedingly rare tumor in black patients."2.43Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman. ( Colby, KA; Nagel, DS, 2005)
"Conjunctival melanoma is extremely rare in children and has low rates of resolution."1.72Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma. ( María Moral, R; María Peiró, A; Monteagudo, C; Moreno, L; Muriel, J, 2022)
"BACKGROUND Conjunctival squamous cell carcinoma is the most common non-pigmented malignancy of the ocular surface."1.56Clinical Management of Squamous Cell Carcinoma of the Conjunctiva. ( Bartz-Schmidt, KU; Bösmüller, HC; Bramkamp, M; Milla, J; Röck, D; Röck, T, 2020)
"Squamous cell carcinoma is the most common malignant tumor of the bulbar conjunctiva."1.51[Management of squamous cell carcinoma of the conjunctiva in a young patient: Case report]. ( Abdou, T; Benhadouch, R; Dib, S, 2019)
"The aim of the study is to evaluate the long-term clinical results of amniotic membrane transplantation (AMT) combined with mitomycin C (MMC) for reconstruction of conjunctival defects created during the excision of ocular surface squamous neoplasia (OSSN)."1.46Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision. ( Hanada, K; Miyokawa, N; Nishikawa, N; Yoshida, A, 2017)
"Two of eight patients (25 %) with squamous cell carcinoma (SCC) had positive lateral margins."1.39Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva. ( Arvas, S; Pazarli, H; Sarici, AM, 2013)
"He was diagnosed with conjunctival squamous cell carcinoma and treated with topical mitomycin C (MMC)."1.37Herpes keratitis in a patient undergoing treatment with topical mitomycin C. ( Amorese, L; Foster, S; Gonzalez-Gonzalez, LA; Shaikh, M; Siddique, SS, 2011)
"The lesion was diagnosed as invasive squamous cell carcinoma on histopathology and topical 0."1.37Periocular allergic contact dermatitis following topical Mitomycin C eye drop application. ( Cavdar, M; Cumurcu, T; Sener, S, 2011)
"05%) combined with MMC (0."1.33Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. ( Erbilen, E; Tunc, M, 2006)
" If Mitomycin is used in that low dosage and in that special application as shown, it could be a very efficient therapy with less complications."1.31[The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years]. ( Klaehsen, D; Maier, M; Merté, RL; Schmidt, M; Schmidt, T, 2001)
"We observed euploid DNA-polyploidy and cytomorphological changes in all patients (19/19)."1.31Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. ( Böcking, A; Cartsburg, O; Hillenkamp, J; Kallen, C; Pomjanski, N; Sundmacher, R, 2001)
"DNA cytometry showed nonaneuploidy in all of these."1.30Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva. ( Böcking, A; Kersten, A; Krallmann, R; Motherby, H; Nadjari, B; Ross, B; Sundmacher, R, 1999)

Research

Studies (137)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's15 (10.95)18.2507
2000's63 (45.99)29.6817
2010's43 (31.39)24.3611
2020's16 (11.68)2.80

Authors

AuthorsStudies
Witsberger, EM1
Dalvin, LA1
Patel, SV1
Moratal Peiro, B1
Calvo Garcia, R1
Soler Sanchis, I1
Mata Moret, L1
Cervera Taulet, E1
Kozma, K1
Dömötör, ZR1
Csutak, A1
Szabó, L1
Hegyi, P1
Erőss, B1
Helyes, Z1
Molnár, Z1
Dembrovszky, F1
Szalai, E1
Sammarco, MG2
Pagliara, MM2
Savino, G1
Giannuzzi, F1
Carlà, MM1
Caputo, CG1
Blasi, MA2
Nuessle, S1
Auw-Haedrich, C2
Jiang, J2
Boehringer, D1
Reinhard, T2
Böhringer, D1
Auw-Hädrich, C1
Maier, PC1
Barth, T1
Eter, N1
Fuest, M1
Geerling, G1
Heindl, LM1
Herwig-Carl, M1
Hintschich, C1
Hufendiek, K1
Kampik, D1
Lieb, W1
Meller, D2
Mueller, A1
Pfeiffer, N1
Rehak, M1
Schargus, M1
Seitz, B1
Spitzer, M1
Stahl, A1
Süsskind, D1
van Oterendorp, C1
Wagner, FM1
Westekemper, H4
Ziemssen, F1
Monroy, D1
Serrano, A1
Galor, A3
Karp, CL4
Alvarado-Castillo, B1
Santa Cruz-Pavlovich, FJ1
Gonzalez-Castillo, C1
Vidal-Paredes, IA1
Garcia-Benavides, L1
Rosales-Gradilla, ME1
Navarro-Partida, J1
Suman, S1
Kumar, A1
Röck, T1
Bartz-Schmidt, KU1
Bramkamp, M1
Milla, J1
Bösmüller, HC1
Röck, D1
Mazzini, C1
Pieretti, G1
Vicini, G1
Nicolosi, C1
Virgili, G1
Giansanti, F1
Manthey, A1
Bechrakis, N1
Soto, H1
Bowen, RC1
Raval, V1
Yeaney, G1
Singh, A1
Aboumourad, RJ1
María Moral, R1
Monteagudo, C1
Muriel, J1
Moreno, L1
María Peiró, A1
Minot, M1
Gonzalvez, M1
Denis, D1
David, T1
Parrozzani, R1
Frizziero, L1
Midena, E1
Scholz, SL1
Eckstein, A1
Dekowski, D1
Esser, J1
Steuhl, KP3
Kaimbo Wa Kaimbo, D1
Maceroni, M1
Singh, M1
Gautam, N1
Kaur, M1
Chaparro Tapias, TA1
Díaz Díaz, AL1
Secondi, R1
Coy Villamil, H1
Sánchez España, JC1
Polski, A1
Sibug Saber, M1
Kim, JW1
Berry, JL1
Ma, IH1
Hu, FR1
Wang, IJ1
Chen, WL1
Hsu, YJ1
Chu, HS1
Yuan, CT1
Hou, YC1
Santoni, A1
Thariat, J1
Maschi, C1
Herault, J1
Baillif, S1
Lassalle, S1
Peyrichon, ML1
Salleron, J1
Caujolle, JP1
Herwig-Carl, MC1
Grossniklaus, HE2
Müller, PL1
Atzrodt, L1
Loeffler, KU1
Dib, S1
Benhadouch, R1
Abdou, T1
Yuksel, D1
Kosker, M1
Reddy, JC1
Celik, T1
Besley, J2
Lee, GA2
Whitehead, K1
Shah, P1
Nanji, AA1
Sayyad, FE1
Sarici, AM1
Arvas, S1
Pazarli, H1
Lee, JH1
Kim, YH1
Kim, MS1
Kim, EC1
Kim, BH1
Kim, MK1
Wee, WR1
Oh, JY1
Pappalardo, J1
Hirst, LW2
Vincent, SJ1
Salazar Méndez, R1
Baamonde Arbaiza, B1
de la Roz Martín, P1
Parra Rodríguez, T1
de la Cruz Aguiló, RI1
Duch-Samper, A1
Hernández Pérez, D1
Marí Cotino, J1
Kempin, R1
Tost, F2
El Hamichi, S1
Messaoudi, R1
Belmalih, M1
Iferkhass, S1
Zerrouk, R1
Reda, K1
Oubaaz, A1
Shah, KJ1
Mogilishetty, G1
Holland, EJ2
Vazirani, J1
Mohapatra, S1
Hanada, K2
Nishikawa, N2
Miyokawa, N2
Yoshida, A2
Kusumesh, R1
Ambastha, A1
Kumar, S1
Sinha, BP1
Imam, N1
Porubská, K1
Rohrbach, JM1
Damato, B1
Coupland, SE1
Schallenberg, M1
Niederdräing, N1
Rahimi, F1
Alipour, F1
Ghazizadeh Hashemi, H1
Hashemian, MN1
Mehrdad, R1
Cunneen, TS1
Conway, RM2
Madigan, MC1
Gentile, CM1
Burchakchi, AI1
Oscar, CJ1
Rudkin, AK1
Muecke, JS1
Zimmermann, P1
Dietrich, T1
Bock, F1
Horn, FK1
Hofmann-Rummelt, C1
Kruse, FE1
Cursiefen, C1
Zaki, AA1
Farid, SF1
Evert, M1
Robinson, L1
McKellar, M1
Fitzharris, B1
Elder, M1
Grover, S1
Jacobs, DS1
Colby, KA3
Gupta, A1
Muecke, J2
Hoyer, A1
Raiskup, F1
Pillunat, E1
Shildkrot, Y2
Wilson, MW4
Birkholz, ES1
Goins, KM1
Sutphin, JE3
Kitzmann, AS1
Wagoner, MD1
Siddique, SS1
Gonzalez-Gonzalez, LA1
Amorese, L1
Shaikh, M1
Foster, S1
Sugandhi, P1
George, RE1
Freistuehler, M1
Anastassiou, G1
Nareyeck, G1
Zeschnigk, M1
Bornfeld, N1
Scheulen, ME1
Hilger, RA1
Cumurcu, T1
Sener, S1
Cavdar, M1
Ditta, LC1
Shields, CL5
Ramasubramanian, A1
Mellen, PL1
Shields, JA5
Tokusashi, Y1
Rodríguez Feijoo, D1
Romero Moreno, I1
López Gutierrez, C1
Usabiaga Usandizaga, M1
Cisneros Carpio, M1
Amias Gorostiza, A1
Alberdi Alberdi, J1
Oellers, P1
Kao, AA1
Abdelaziz, A1
Feuer, W1
Dubovy, SR1
Jain, S1
Chandravanshi, SL1
Rathore, MK1
Goyal, P1
Jain, SC1
Tsakalaki, V1
Halkia, A1
Haniotis, V1
Kafousi, M1
Detorakis, ET1
Papandroudis, AA1
Dimitrakos, SA1
Stangos, NT1
Yuen, HK1
Yeung, EF1
Chan, NR1
Chi, SC1
Lam, DS1
Panda, A2
Sudan, R2
Naseripour, M2
Eagle, RC1
Rodríguez-Pérez, C1
Del Campo, Z1
Wolley-Dod, C1
Gris, O1
Bajaj, MS1
Balasubramanya, R1
Prakash, G1
Snyder, ME1
Sacu, S1
Ségur-Eltz, N1
Horvat, R1
Lukas, JR1
Zehetmayer, M1
Groh, MJ1
Holbach, LM1
Kühnel, B1
Naumann, GO1
Rosner, M1
Hadar, I1
Rosen, N1
Di Pascuale, MA1
Espana, EM1
Tseng, SC1
Dudney, BW1
Malecha, MA1
Ramos-López, JF1
Martínez-Costa Pérez, R1
Cisneros Lanuza, AL1
Francés Muñoz, E1
Monte Boque, E1
Muñoz Gómez, MC1
López-Sánchez, EV1
Menezo Rozalén, JL1
Kopp, ED1
Seregard, S1
Demirci, H2
Marr, BP1
Masheyekhi, A1
Materin, M1
Stone, DU1
Butt, AL1
Chodosh, J1
Nagel, DS1
Prabhasawat, P1
Tarinvorakup, P1
Tesavibul, N1
Uiprasertkul, M1
Kosrirukvongs, P1
Booranapong, W1
Srivannaboon, S1
Kurli, M1
Finger, PT5
Becerra, EM1
Blanco, G1
Saornil, MA1
del C Méndez, M1
Bianciotto, CG1
Krohn, J1
Monge, OR1
Singh, AD1
Jacques, R1
Rundle, PA1
Rennie, IG1
Mudhar, HS1
Slater, D1
Abraham, LM1
Selva, D1
Casson, R1
Leibovitch, I1
Khong, JJ1
Tunc, M1
Erbilen, E1
Chang, SW1
Huang, ZL1
Huerva, V2
Mateo, AJ1
Mangues, I2
Jurjo, C1
Ozcan, AA1
Sizmaz, S1
Yagmur, M1
Sugiura, M1
Mihm, MC1
Zembowicz, A1
Yu, CS1
Chiu, SI1
Ng, CS1
Chan, HH1
Tse, RK1
Pournaras, JA1
Chamot, L1
Uffer, S1
Zografos, L1
Char, DH1
Crawford, JB1
Anandajeya, WV1
Corrêa, ZM1
Augsburger, JJ1
Gericke, A1
Pitz, S1
Strempel, I1
Sekundo, W1
Milner, MS1
McCormick, SA2
Löffler, KU1
Frucht-Pery, J3
Sugar, J1
Baum, J1
Pe'er, J2
Savir, H1
Meisler, DM1
Foster, JA1
Folberg, R2
Rozenman, Y3
Hungerford, JL1
George, SM1
Madreperla, SA1
Aaberg, TM1
Heigle, TJ1
Stulting, RD1
Palay, DA1
Gebhardt, DO1
Czechonska, G1
Liarikos, S1
Werschnik, C1
Lommatzsch, PK1
Akpek, EK1
Ertoy, D1
Kalayci, D1
Hasiripi, H1
Haas, K1
Ben-Dor, D1
Levartovsky, S1
Hardten, DR1
Samuelson, TW1
Salomão, DR1
Mathers, WD1
Cuevas, K1
Nadjari, B2
Kersten, A2
Ross, B1
Motherby, H1
Krallmann, R1
Sundmacher, R3
Böcking, A3
Hawkins, AS1
Yu, J1
Hamming, NA1
Rubenstein, JB1
Schelonka, LP1
Siegel, D1
Meininger, A1
Ross, D1
Joseph, A1
Sabri, K1
Dua, HS1
Paridaens, D1
Beekhuis, H1
van Den Bosch, W1
Remeyer, L1
Melles, G1
Cartsburg, O2
Pomjanski, N2
McKelvie, PA1
Daniell, M2
Armstrong, T1
Siganos, CS1
Kozobolis, VP1
Christodoulakis, EV1
Schmidt, M1
Maier, M1
Schmidt, T1
Klaehsen, D1
Merté, RL1
Yamamoto, N1
Ohmura, T1
Suzuki, H1
Shirasawa, H1
Khokhar, S1
Soni, A1
SinghSethi, H1
Sony, P1
Pangtey, MS1
Maini, R1
Tole, D1
Kallen, C1
Hillenkamp, J1

Reviews

14 reviews available for mitomycin and Conjunctival Neoplasms

ArticleYear
Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.
    Scientific reports, 2022, 08-20, Volume: 12, Issue:1

    Topics: Administration, Topical; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Eye Neoplasms; Fluorourac

2022
Medical treatment for ocular surface squamous neoplasia.
    Eye (London, England), 2023, Volume: 37, Issue:5

    Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Eye Neoplasms; Fluorouracil; Humans; Interferon al

2023
[Diagnosis and Therapy of Benign and Malignant Tumors of the Conjunctiva].
    Klinische Monatsblatter fur Augenheilkunde, 2020, Volume: 237, Issue:9

    Topics: Adult; Child; Conjunctiva; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Neoplasm Recurrence,

2020
[Current Therapies in Superficial Malignant Tumors].
    Klinische Monatsblatter fur Augenheilkunde, 2018, Volume: 235, Issue:10

    Topics: Conjunctival Neoplasms; Humans; Mitomycin; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Out

2018
Topical chemotherapy for ocular surface squamous neoplasia.
    Current opinion in ophthalmology, 2013, Volume: 24, Issue:4

    Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms;

2013
[Topical chemotherapy for conjunctival tumours - the medical and legal bearings of the case].
    Klinische Monatsblatter fur Augenheilkunde, 2014, Volume: 231, Issue:6

    Topics: Administration, Ophthalmic; Antineoplastic Agents; Chemotherapy, Adjuvant; Conjunctival Neoplasms; C

2014
Ocular Surface Squamous Neoplasia in a Living-Related Conjunctival Limbal Allograft.
    Cornea, 2016, Volume: 35, Issue:2

    Topics: Aged; Allografts; Antibiotics, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Conjunc

2016
[Topical Mitomycin C as a therapy of conjunctival tumours].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2008, Volume: 105, Issue:8

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; C

2008
[Conjunctival tumours in elderly patients].
    Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined

2010
Treatment of ocular surface squamous neoplasia with Mitomycin C.
    The British journal of ophthalmology, 2010, Volume: 94, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuva

2010
Conjunctival melanoma: pitfalls and dilemmas in management.
    Current opinion in ophthalmology, 2010, Volume: 21, Issue:5

    Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Cryotherapy; Humans; Lymphatic Metastasis; Mela

2010
Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
    Cornea, 2005, Volume: 24, Issue:3

    Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Black People; Combined Modality Therapy

2005
Mitomycin: clinical applications in ophthalmic practice.
    Drugs, 2006, Volume: 66, Issue:3

    Topics: Antibiotics, Antineoplastic; Cicatrix; Conjunctival Neoplasms; Glaucoma; Humans; Melanoma; Mitomycin

2006
Ocular toxicity of mitomycin-C.
    International ophthalmology clinics, 1999,Spring, Volume: 39, Issue:2

    Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Eye; Eye Diseases; Filtering Surgery; Glaucoma;

1999

Trials

9 trials available for mitomycin and Conjunctival Neoplasms

ArticleYear
Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
    BMC ophthalmology, 2023, Jul-27, Volume: 23, Issue:1

    Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunc

2023
Treatment of ocular surface squamous neoplasia with Mitomycin C.
    The British journal of ophthalmology, 2010, Volume: 94, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuva

2010
[Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:9

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Female; Humans; Male;

2003
Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Ophthalmology, 2007, Volume: 114, Issue:5

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S

2007
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Ophthalmology, 1997, Volume: 104, Issue:12

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S

1997
Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    The British journal of ophthalmology, 1998, Volume: 82, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Conjuncti

1998
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2000, Volume: 118, Issue:7

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Atrophy; Chemotherapy, Adjuvant;

2000
Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
    Clinical & experimental ophthalmology, 2002, Volume: 30, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S

2002
Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    American journal of ophthalmology, 2002, Volume: 133, Issue:5

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc

2002

Other Studies

115 other studies available for mitomycin and Conjunctival Neoplasms

ArticleYear
Visualizing Ocular Surface Squamous Neoplasia.
    Ophthalmology, 2022, Volume: 129, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival

2022
Advancing wavelike epitheliopathy after conjunctival intraepithelial neoplasia. Atipical case report.
    Archivos de la Sociedad Espanola de Oftalmologia, 2022, Volume: 97, Issue:6

    Topics: Administration, Topical; Carcinoma in Situ; Conjunctival Neoplasms; Corneal Diseases; Humans; Mitomy

2022
Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:8

    Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Eye Neoplasms; Humans; Hyaluronic Acid; Lubricant

2023
Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2023, Volume: 261, Issue:4

    Topics: Adjuvants, Immunologic; Conjunctival Neoplasms; Humans; Interferon-alpha; Melanosis; Mitomycin; Neop

2023
Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany.
    Klinische Monatsblatter fur Augenheilkunde, 2023, Volume: 240, Issue:7

    Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Humans; Interferon-alpha; Mitomycin; Ophthalmic So

2023
Intraoperative mitomycin C and cryotherapy as adjunct therapy for recurrent lobular capillary haemangioma of conjunctiva.
    BMJ case reports, 2020, Jan-07, Volume: 13, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Cryotherapy;

2020
Clinical Management of Squamous Cell Carcinoma of the Conjunctiva.
    The American journal of case reports, 2020, Feb-01, Volume: 21

    Topics: Adult; Ambulatory Surgical Procedures; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjun

2020
Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C.
    European journal of ophthalmology, 2021, Volume: 31, Issue:6

    Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Male; Melanoma; Melanosis; Middle Aged;

2021
Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
    The British journal of ophthalmology, 2022, Volume: 106, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Conjunctival Neoplasms; Female; Humans; Melanoma; Melanoma,

2022
Case Series: High-resolution Optical Coherence Tomography as an Optical Biopsy in Ocular Surface Squamous Neoplasia.
    Optometry and vision science : official publication of the American Academy of Optometry, 2021, 05-01, Volume: 98, Issue:5

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; C

2021
Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma.
    European journal of ophthalmology, 2022, Volume: 32, Issue:6

    Topics: Child; Conjunctival Neoplasms; Humans; In Situ Hybridization, Fluorescence; Melanoma; Mitomycin; Rar

2022
[Impressive regression of a conjunctival carcinoma with topical mitomycin C].
    Journal francais d'ophtalmologie, 2021, Volume: 44, Issue:9

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctiva; Conjunct

2021
Giant Ocular Surface Squamous Cell Papilloma Treated With Topical Mitomycin C.
    JAMA ophthalmology, 2017, 07-13, Volume: 135, Issue:7

    Topics: Administration, Ophthalmic; Aged; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Male;

2017
Excision and topical 0.04% mitomycin C for extensive and recurrent conjunctival squamous cell carcinoma in an AIDS patient. A case report.
    Journal francais d'ophtalmologie, 2017, Volume: 40, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Co

2017
Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    European journal of ophthalmology, 2018, Volume: 28, Issue:2

    Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Alkylating Agents; Carcinoma in Situ; Ca

2018
Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
    International ophthalmology, 2019, Volume: 39, Issue:2

    Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Dr

2019
Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
    Archivos de la Sociedad Espanola de Oftalmologia, 2018, Volume: 93, Issue:11

    Topics: Administration, Ophthalmic; Aged; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Conjunctival Neo

2018
Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
    Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:2

    Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disea

2019
Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2019, Volume: 118, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neopla

2019
Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.
    American journal of ophthalmology, 2019, Volume: 200

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival

2019
Pyogenic granuloma associated with conjunctival epithelial neoplasia: report of nine cases.
    The British journal of ophthalmology, 2019, Volume: 103, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcino

2019
[Management of squamous cell carcinoma of the conjunctiva in a young patient: Case report].
    Journal francais d'ophtalmologie, 2019, Volume: 42, Issue:4

    Topics: Adult; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Co

2019
Management of cataracts and oculo-cutaneous malignancy in xeroderma pigmentosum.
    Seminars in ophthalmology, 2013, Volume: 28, Issue:2

    Topics: Adolescent; Biological Dressings; Carcinoma, Squamous Cell; Cataract; Conjunctival Neoplasms; Female

2013
Can augmented trabeculectomies cause iatrogenic melanoma?
    Clinical & experimental ophthalmology, 2014, Volume: 42, Issue:2

    Topics: Alkylating Agents; Chemotherapy, Adjuvant; Conjunctival Neoplasms; Eye Enucleation; Female; Glaucoma

2014
Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous

2013
The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Seminars in ophthalmology, 2014, Volume: 29, Issue:4

    Topics: Aged; Alkylating Agents; Amnion; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neoplasm

2014
Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Carcinoma in Situ; Carcinoma, S

2013
Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc

2014
[Treatment of conjunctival melanoma].
    Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:2

    Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Biopsy; Chemotherapy, Adjuvant; Combined Modal

2014
Conjunctival intraepithelial neoplasia. Interferon as a rescue therapy after failure of mitomycin C.
    Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:11

    Topics: Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Drug Resistance, Neoplasm; Drug Su

2014
Bilateral enucleation avoided by excision with mitomycin C for bilateral infiltrating conjunctival squamous cell carcinoma in a girl with xeroderma pigmentosum.
    Journal francais d'ophtalmologie, 2015, Volume: 38, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Conjunctival Neop

2015
Ocular Surface Squamous Neoplasia.
    JAMA ophthalmology, 2016, Volume: 134, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disease

2016
Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.
    International ophthalmology, 2017, Volume: 37, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amnion; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combi

2017
Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Cornea, 2017, Volume: 36, Issue:3

    Topics: Administration, Topical; Alkylating Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Female

2017
[Unclear monocular chronic reddening of the conjunctiva with ptosis].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2008, Volume: 105, Issue:9

    Topics: Antibiotics, Antineoplastic; Blepharoptosis; Carcinoma in Situ; Conjunctival Neoplasms; Follow-Up St

2008
An audit of conjunctival melanoma treatment in Liverpool.
    Eye (London, England), 2009, Volume: 23, Issue:4

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Brachytherapy;

2009
Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
    Archives of Iranian medicine, 2009, Volume: 12, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Cornea;

2009
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:4

    Topics: Apoptosis; Butyrates; Cell Cycle; Cell Proliferation; Cell Survival; Conjunctival Neoplasms; Connect

2009
In vivo confocal microscopy study of ocular surface neoplasia manifesting after radial keratotomy and laser in situ keratomileusis.
    Cornea, 2009, Volume: 28, Issue:3

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Corn

2009
Mitomycin-C as adjuvant therapy in the treatment of sebaceous gland carcinoma in high-risk locations.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:4

    Topics: Adenocarcinoma, Sebaceous; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuv

2009
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma.
    The British journal of ophthalmology, 2009, Volume: 93, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Female; Humans;

2009
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Cornea, 2009, Volume: 28, Issue:9

    Topics: Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy

2009
Topical mitomycin C for the local treatment of a primary diffuse large B-cell lymphoma of the palpebral conjunctiva.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:9

    Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Lymphom

2009
Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma.
    Cornea, 2010, Volume: 29, Issue:4

    Topics: Aged; Alkylating Agents; Artificial Organs; Conjunctival Neoplasms; Corneal Diseases; Epithelium, Co

2010
[Mitomycin C in diffuse multilocal malignant conjunctival melanoma].
    Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:5

    Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Treatment Outcome

2010
Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
    Cornea, 2011, Volume: 30, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biopsy; Carcinoma in Situ; Chemotherapy

2011
Herpes keratitis in a patient undergoing treatment with topical mitomycin C.
    Cornea, 2011, Volume: 30, Issue:4

    Topics: Aged; Antibiotics, Antineoplastic; Antiviral Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasm

2011
Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
    Cornea, 2011, Volume: 30, Issue:4

    Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Con

2011
Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agents.
    International journal of clinical pharmacology and therapeutics, 2011, Volume: 49, Issue:1

    Topics: Antineoplastic Agents; Cell Line, Tumor; Conjunctival Neoplasms; Humans; Melanoma; Mitomycin; Nitros

2011
Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
    Cutaneous and ocular toxicology, 2011, Volume: 30, Issue:3

    Topics: Administration, Topical; Adrenal Cortex Hormones; Antibiotics, Antineoplastic; Carcinoma, Squamous C

2011
Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ophthalmology, 2011, Volume: 118, Issue:9

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N

2011
Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Ophthalmology, 2011, Volume: 118, Issue:11

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Female; Graft Rejection; HIV Infectio

2011
Pigmented squamous cell carcinoma in situ of the conjunctiva.
    Japanese journal of ophthalmology, 2011, Volume: 55, Issue:5

    Topics: Amnion; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplas

2011
[Conjunctival keratoacanthoma: diagnosis, treatment and monitoring by conjunctival impression cytology].
    Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87, Issue:3

    Topics: Adult; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Diseases; Conjunctival Neop

2012
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
    Ophthalmology, 2012, Volume: 119, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms;

2012
Huge malignant melanoma of caruncle with extensive involvement of conjunctiva.
    Journal of the Indian Medical Association, 2012, Volume: 110, Issue:2

    Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Cryotherapy; Humans;

2012
Conjunctival seborrheic keratosis manifesting as squamous carcinoma.
    Ophthalmology, 2013, Volume: 120, Issue:2

    Topics: Alkylating Agents; Carcinoma, Squamous Cell; Conjunctival Diseases; Conjunctival Neoplasms; Diagnosi

2013
Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
    Cornea, 2002, Volume: 21, Issue:7

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Corneal Diseases; Eye

2002
The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
    Cornea, 2002, Volume: 21, Issue:8

    Topics: Adult; Antibiotics, Antineoplastic; Conjunctiva; Conjunctival Neoplasms; Humans; Male; Mitomycin; Ne

2002
Comment on intraoperative use of mitomycin C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
    Cornea, 2002, Volume: 21, Issue:8

    Topics: Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Co

2002
Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma.
    Ophthalmology, 2002, Volume: 109, Issue:11

    Topics: Adenocarcinoma, Sebaceous; Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineopla

2002
[Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Archivos de la Sociedad Espanola de Oftalmologia, 2002, Volume: 77, Issue:12

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co

2002
Topical mitomycin C for conjunctival-corneal squamous cell carcinoma.
    American journal of ophthalmology, 2003, Volume: 135, Issue:1

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplas

2003
Conjunctival intraepithelial neoplasia.
    Ophthalmology, 2003, Volume: 110, Issue:7

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in

2003
Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
    American journal of ophthalmology, 2003, Volume: 136, Issue:2

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Cataract; Cataract Extraction; Conjunctival Ne

2003
Successful treatment with mitomycin C eye drops for conjunctival diffuse intraepithelial neoplasia with sebaceous features.
    Ophthalmic plastic and reconstructive surgery, 2003, Volume: 19, Issue:6

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Female; Humans; Mitomy

2003
A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
    Cornea, 2004, Volume: 23, Issue:1

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma in Situ; Conj

2004
Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co

2004
[Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:8

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasm

2004
Epiphora as a side effect of topical mitomycin C.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:11

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N

2004
Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:1

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc

2005
Ocular surface squamous neoplasia: a standard of care survey.
    Cornea, 2005, Volume: 24, Issue:3

    Topics: Administration, Topical; Antineoplastic Agents; Biopsy; Combined Modality Therapy; Conjunctival Neop

2005
Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Cornea, 2005, Volume: 24, Issue:4

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squ

2005
Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:11

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N

2005
Hughes technique, amniotic membrane allograft, and topical chemotherapy in conjunctival melanoma with eyelid involvement.
    Ophthalmic plastic and reconstructive surgery, 2005, Volume: 21, Issue:3

    Topics: Administration, Topical; Amnion; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva

2005
[Conjunctival primary acquired melanosis].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2005, Sep-22, Volume: 125, Issue:18

    Topics: Aged; Antibiotics, Antineoplastic; Conjunctival Diseases; Conjunctival Neoplasms; Cryotherapy; Diagn

2005
Neoadjuvant topical mitomycin C chemotherapy for conjunctival and corneal intraepithelial neoplasia.
    Eye (London, England), 2006, Volume: 20, Issue:9

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Cornea; Humans; Male;

2006
Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
    The British journal of ophthalmology, 2006, Volume: 90, Issue:7

    Topics: Adenocarcinoma, Sebaceous; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell;

2006
Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.
    The British journal of ophthalmology, 2006, Volume: 90, Issue:7

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Corneal Diseases; Drug

2006
Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
    American journal of ophthalmology, 2006, Volume: 142, Issue:4

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival N

2006
Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis.
    Cornea, 2006, Volume: 25, Issue:6

    Topics: Administration, Oral; Alkylating Agents; Child; Cimetidine; Combined Modality Therapy; Conjunctival

2006
Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.
    Cornea, 2006, Volume: 25, Issue:10

    Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy;

2006
Topical mitomycin C for the treatment of conjunctival tumor.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2007, Volume: 221, Issue:1

    Topics: Administration, Topical; Adult; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; C

2007
Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
    The American journal of surgical pathology, 2007, Volume: 31, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cell Nucleolus; Cell Nucleus; Chemother

2007
Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy.
    International ophthalmology, 2008, Volume: 28, Issue:1

    Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Biopsy; Conjunctival Neoplasms; Female;

2008
Conjunctival intraepithelial neoplasia in a patient treated with tacrolimus after liver transplantation.
    Cornea, 2007, Volume: 26, Issue:10

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neopla

2007
Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:3

    Topics: Administration, Topical; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Con

2008
Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
    Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:3

    Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Fl

2008
Primary acquired melanosis with atypia treated with mitomycin C.
    International ophthalmology, 2009, Volume: 29, Issue:4

    Topics: Alkylating Agents; Conjunctival Diseases; Conjunctival Neoplasms; Cryosurgery; Humans; Male; Melanom

2009
[Bilateral ocular surface squamous neoplasia and neurodermatitis. Two cases with different courses].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2008, Volume: 105, Issue:12

    Topics: Adult; Antibiotics, Antineoplastic; Biological Dressings; Carcinoma, Squamous Cell; Chemotherapy, Ad

2008
Topical chemotherapy for conjunctival melanoma.
    The British journal of ophthalmology, 1993, Volume: 77, Issue:11

    Topics: Administration, Topical; Conjunctiva; Conjunctival Neoplasms; Female; Humans; Melanoma; Middle Aged;

1993
[Mitomycin as local therapeutic drug in ocular neoplasms].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1997, Volume: 94, Issue:7

    Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Corneal Diseases; Eye Neoplasms; Follow-Up Stud

1997
Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    American journal of ophthalmology, 1997, Volume: 124, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplas

1997
Mitomycin C treatment of conjunctival intraepithelial neoplasia.
    American journal of ophthalmology, 1997, Volume: 124, Issue:3

    Topics: Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Humans; Mitomycin; Ophthalmi

1997
Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
    American journal of ophthalmology, 1997, Volume: 124, Issue:3

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co

1997
Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    American journal of ophthalmology, 1998, Volume: 125, Issue:3

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Cor

1998
[Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Klinische Monatsblatter fur Augenheilkunde, 1998, Volume: 212, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Ther

1998
Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Cornea, 1999, Volume: 18, Issue:1

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Conjunctival Ne

1999
Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:4

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasm

1999
Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Ophthalmology, 1999, Volume: 106, Issue:9

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Biopsy; Cell Nucleus; Conjunctiva; Conju

1999
Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.
    Analytical and quantitative cytology and histology, 1999, Volume: 21, Issue:5

    Topics: Aneuploidy; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival N

1999
Treatment of recurrent conjunctival papillomatosis with mitomycin C.
    American journal of ophthalmology, 1999, Volume: 128, Issue:5

    Topics: Antibiotics, Antineoplastic; Child, Preschool; Conjunctival Neoplasms; Female; Humans; Mitomycin; Ne

1999
Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C.
    Cornea, 2000, Volume: 19, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Diagnosis, Diff

2000
Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes.
    Investigative ophthalmology & visual science, 2000, Volume: 41, Issue:7

    Topics: Antibodies, Monoclonal; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctiva; Conjunctival Neopl

2000
Surgical excision, autolimbal transplantation, and mitomycin C in the treatment of conjunctival and corneal intraepithelial neoplasia.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:5

    Topics: Adult; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Corne

2001
Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:6

    Topics: Administration, Topical; Aged; Amnion; Conjunctival Neoplasms; Corneal Transplantation; Female; Huma

2001
[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Klinische Monatsblatter fur Augenheilkunde, 2001, Volume: 218, Issue:6

    Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality

2001
Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:9

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Conjunctival Neoplasm

2001
Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy.
    American journal of ophthalmology, 2001, Volume: 132, Issue:4

    Topics: Adult; Amnion; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Corne

2001
The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
    Cornea, 2002, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; C

2002
[The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Klinische Monatsblatter fur Augenheilkunde, 2001, Volume: 218, Issue:12

    Topics: Administration, Topical; Aged; Biopsy; Cell Transformation, Neoplastic; Conjunctiva; Conjunctival Ne

2001
Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C.
    Ophthalmology, 2002, Volume: 109, Issue:2

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neopla

2002
Combined surgery, cryotherapy, and mitomycin-C for recurrent ocular surface squamous neoplasia.
    Cornea, 2002, Volume: 21, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctiva

2002
Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
    Ophthalmology, 2002, Volume: 109, Issue:3

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc

2002
Topical mitomycin C and radiation induce conjunctival DNA-polyploidy.
    Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology, 2001, Volume: 23, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therap

2001